Navigation Links
First electrophysical recording of sleep in a wild animal
Date:5/13/2008

In the first experiment to record the electrophysiology of sleep in a wild animal, three-toed sloths carrying miniature electroencephalogram recorders slept 9.63 hours per day6 hours less than captive sloths did, reports an international team of researchers working on the Smithsonian Tropical Research Institutes Barro Colorado Island in Panama.

We are fascinated that some species sleep far longer than others. If we can determine the reasons for variations in sleep patterns, we will gain insight into the function of sleep in mammals, including humans, said first author Niels Rattenborg, group leader of the Sleep and Flight Group at the Max Planck Institute for Ornithology. If animals behave differently in captivity (where all previous comparative studies were performed) than they do in the wild, measuring their brain activity in captivity can lead to the wrong conclusions.

The research team got around this problem by using a technique developed for monitoring brain activity in humans in conjunction with a newly developed miniature recorder for neurophysiological data in order to monitor sleep in the wild.

In addition to two brain activity sensors worn as a cap on their heads, three adult three-toed sloths, Bradypus variegatus, also were fitted with radio-telemetry collars and accelerometers so that their exact locations and movements could be monitored during the next three to five days. The activity of two other sloths was monitored via radio-telemetry collar alone, for approximately seven months using a unique Automated Radio Telemetry System in place on the island.

The placement of sensors on sloths living in treetops demonstrates the feasibility of understanding a complex behavior, such as sleep, in the intricate tropical forest environment. It also will lead to more refined, comparative sleep research.

The beauty of the automated telemetry system is that it makes a new suite of animal behavior studies possible, said Martin Wikel
'/>"/>

Contact: Beth King
kingb@si.edu
703-487-3772, ext. 8216
Smithsonian Tropical Research Institute
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First electrophysical recording of sleep in a wild animal
First electrophysical recording of sleep in a wild animal
(Date:12/2/2009)... Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ... dose confirmation and dosimetry trial of Cotara® in patients ... brain cancer. Cotara is a targeted monoclonal antibody ... new treatment for GBM. Cotara specifically targets cells ...
(Date:12/2/2009)... - "Bolstering Biodiversity in Africa: ... Coinciding with the International Year of Biodiversity, ... international conference in Libreville,(Gabon) on the issue of ... attended by government and state leaders, ministers,scientific experts, ...
(Date:12/2/2009)... TechConnect World, an event bringing together the ... cleantech, nanotech, biotech and MEMS, announced the December ... ,, Now in its 14th year, TechConnect World, ... Institute (NSTI), and the Clean Technology and Sustainable ...
(Date:12/2/2009)... Ltd today announced data presentations on its novel oral ... 51st Annual Meeting and Exposition in New Orleans. ,, ... the Phase 1 dose-escalation trial of SB1518 detailing its ... ranging from 100 to 600 mg. These doses were ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
... clinical-stage biopharmaceutical company focused on diseases of epidemic potential, ... for SQ109 with the dosing of the first cohort ... replace one or more of the current first-line antitubercular ... Fast Track designation and FDA/EMEA Orphan Drug Designation in ...
... Syrinx Consulting Corporation , an IT consulting ... SharePoint applications , announced today that ... a leading biopharmaceutical company in the Boston area. ... gigabytes of data from a SharePoint 2003 environment to ...
... biotechnology research is providing new applications for nutraceutical ... two leading health concerns among consumers. Leading ... www.advanascience.com , will present future ... consumer healthy category at VitaFoods International on Wednesday, ...
Other Biology Technology:Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109 2Syrinx Wins Contract with Leading Pharmaceutical Company for SharePoint 2007 Services 2Industry Expert Reveals Cutting Edge Biotechnology Science for Nutraceutical and Functional Food Applications 2
(Date:12/4/2009)... amyloids the fibrous protein deposits associated with diseases such ... potential new area for therapeutics. , It was believed that ... known as fibres - are inert, but that there may ... and cause disease. , But in a paper published ...
(Date:12/3/2009)... co-workers discovered that specific types of human papillomavirus (HPV) ... pathogens cause cells to degenerate. It is known today ... E7. Both proteins switch off different cellular control functions, ... Rsl and his co-workers at DKFZ have now discovered ...
(Date:12/3/2009)... likened to emptying a museum of its collection, or dumping ... replacing every local cuisine with McDonald,s burgers. , But the ... the world boring. New research now suggests it may also ... , "Habitat destruction and biodiversity loss,"driven by the replacement of ...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Papillomavirus silences innate immune response 2Species down, disease up 2Species down, disease up 3Species down, disease up 4Lives Compromised and Patient Access Limited with New Cuts to Medicare 62021 1Lives Compromised and Patient Access Limited with New Cuts to Medicare 62021 2Statement of Support 3A Strengthening Oral Health Care is Key Part of Health Reform 62018 1Statement of Support 3A Strengthening Oral Health Care is Key Part of Health Reform 62018 2Shire Submits European Marketing Authorization Application 28MAA 29 for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 14957 1Shire Submits European Marketing Authorization Application 28MAA 29 for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 14957 2Shire Submits European Marketing Authorization Application 28MAA 29 for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 14957 3
... WASHINGTON Members of the public can send their ... mission dedicated to understanding the effects of particles in ... , The "Send Your Name Around the Earth" Web ... mission and place their names in orbit for years ...
... Enhanced Applicant,Verification and New Security Features that Combat ... 25 L-1 Identity,Solutions, Inc. (NYSE: ID ... today announced that the Massachusetts Registry of Motor ... a new six-year,contract to upgrade and further enhance ...
... surrounded by the San Bernardino National Forest have taken ... to a U.S. Forest Service study completed this summer., ... A Case Study on the San Bernardino National Forest," ... surveys and focus group discussions in 2007 had taken ...
Other Biology News:Send your name around the Earth on NASA'S Glory mission 2L-1 Identity Solutions Awarded New Massachusetts RMV Driver's License Contract Valued at an Estimated $32 Million 2L-1 Identity Solutions Awarded New Massachusetts RMV Driver's License Contract Valued at an Estimated $32 Million 3Study reveals homeowner perceptions in fire-prone areas 2
...
... Cell Lines stably express the regulatory ... line is functionally tested for induction ... expression control vector pGene/V5-His/lacZ and by ... with mifepristone (Figure 1). These cell ...
... Kit Includes: Sufficient library for ... x 10^9 independent sequences, -28 gIII ... DNA sequencing, -96 gIII Sequencing Primer ... Host E. coli strain ER2738, Control ...
... Materials for 15-20 enhancements when ... Western Blot Signal Enhancement System is designed to ... is an excellent tool for evaluating proteins with low ... to pre-treat membrane prior to blocking the membrane; 1x ...
Biology Products: